Sarcopenia and frailty in older patients with diabetes mellitus

Geriatrics and Gerontology International

Volumn 16, Issue 3, 2016, Pages 293-299

  Umegaki, Hiroyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dementia; Diabetes mellitus; Frailty; Sarcopenia

Indexed keywords

AMINO ACID; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; INCRETIN; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA DERIVATIVE;

ADL DISABILITY; AEROBIC EXERCISE; AGING; CARDIOVASCULAR MORTALITY; CHRONIC INFLAMMATION; COGNITIVE DEFECT; DEPRESSION; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; EXERCISE; FALLING; FRAIL ELDERLY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RESISTANCE TRAINING; REVIEW; SARCOPENIA; THERAPY EFFECT; AGED; COMPLICATION; DIABETIC COMPLICATION;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; FRAIL ELDERLY; HUMANS; SARCOPENIA;

EID: 84959510274     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12688     Document Type: Review

References (78)

1. Abi Khalil C, Roussel R, Mohammedi K, Danchin N, Marre M. Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Cardiovasc Prev Rehabil 2012; 19: 374-381.
2. Eckardt K, Görgens SW, Raschke S, Eckel J. Myokines in insulin resistance and type 2 diabetes. Diabetologia 2014; 57: 1087-1099.
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM etal. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
4. Chen LK, Liu LK, Woo J etal. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101.
5. Park MH, Kim DH, Lee EK etal. Age-related inflammation and insulin resistance: a review of their intricate interdependency. Arch Pharm Res 2014; 37: 1507-1514.
6. Alemán-Mateo H, López Teros MT, Ramírez FA. Astiazarán-García H. Association between insulin resistance and low relative appendicular skeletal muscle mass: evidence from a cohort study in community-dwelling older men and women participants. J Gerontol A Biol Sci Med Sci 2014; 69: 871-877.
7. Schaap L, Pluijim SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006; 119: 526.e9-526.e17.
8. Figueiredo PA, Mota MP, Appell HJ, Duarte JA. The role of mitochondria in aging of skeletal muscle. Biogerontology 2008; 9: 67-84.
9. Calvani R, Joseph AM, Adhihetty PJ etal. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem 2013; 394: 393-414.
10. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci 2012; 67: 1140-1152.
11. Goldspink G, Harridge SD. Growth factors and muscle ageing. Exp Gerontol 2004; 39: 1433-1438.
12. Gonzalez-Freire M, de Cabo R, Studenski SA, Ferrucci L. The neuromuscular junction: aging at the crossroad between nerves and muscle. Front Aging Neurosci. 2014; 6: 208.
13. Morley JE, Vellas B, van Kan GA etal. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14: 392-397.
14. Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med 2006; 166: 418-423.
15. Bibas L, Levi M, Bendayan M, Mullie L, Forman DE, Afilalo J. Therapeutic interventions for frail elderly patients: part I. Published randomized trials. Prog Cardiovasc Dis 2014; 57: 134-143.
16. Wong E, Backholer K, Gearon E etal. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013; 1: 106-114.
17. Kim TN, Park MS, Yang SJ etal. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010; 33: 1497-1499.
18. Ottenbacher KJ, Graham JE, Al Snih S etal. Mexican Americans and frailty: findings from the Hispanic established populations epidemiologic studies of the elderly. Am J Public Health 2009; 99: 673-679.
19. Hubbard RE, Andrew MK, Fallah N, Rockwood K. Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabet Med 2010; 27: 603-606.
20. Cacciatore F, Testa G, Galizia G etal. Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta Diabetol 2013; 50: 251-260.
21. Saum KU, Dieffenbach AK, Müller H, Holleczek B, Hauer K, Brenner H. Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study. Eur J Epidemiol 2014; 29: 171-179.
22. Jung HW, Kim SW, Ahn S etal. Prevalence and outcomes of frailty in Korean elderly population: comparisons of a multidimensional frailty index with two phenotype models. PLoS ONE 2014; 9: e87958.
23. Lee JS, Auyeung TW, Leung J, Kwok T, Leung PC, Woo J. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J Nutr Health Aging 2011; 15: 857-862.
24. Leenders M, Verdijk LB, van der Hoeven L etal. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013; 14: 585-592.
25. Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles - a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia 2009; 52: 1182-1191. doi: 10.1007/s00125-009-1320-0.
26. Andersen H, Nielsen S, Mogensem CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004; 53: 1543-1548.
27. Andersen H, Poulsen PL, Mogensen CE, Jakobsen J. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes 1996; 45: 440-445.
28. Allen MD, Choi IH, Kimpinski K, Doherty TJ, Rice CL. Motor unit loss and weakness in association with diabetic neuropathy in humans. Muscle Nerve 2013; 48: 298-300. doi: 10.1002/mus.23792.
29. Andreassen CS, Jakobsen J, Andersen H. Muscle weakness. A progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 2006; 55: 806-812.
30. Rabøl R, Larsen S, Højberg PM etal. Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity. J Clin Endocrinol Metab 2010; 95: 857-863. doi: 10.1210/jc.2009-1844.
31. Ramamurthy B, Höök P, Jones AD, Larsson L. Changes in myosin structure and function in response to glycation. FASEB J 2001; 15: 2415-2422.
32. Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care 2015; 38: 82-90.
33. Cruz NG, Sousa LP, Sousa MO, Pietrani NT, Fernandes AP, Gomes KB. The linkage between inflammation and Type 2 diabetes mellitus. Diabetes Res Clin Pract 2013; 99: 85-92.
34. Jo E, Lee SR, Park BS, Kim JS. Potential mechanisms underlying the role of chronic inflammation in age-related muscle wasting. Aging Clin Exp Res 2012; 24: 412-422.
35. García-Esquinas E, Graciani A, Guallar-Castillón P, López-García E, Rodríguez-Mañas L, Rodríguez-Artalejo F. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc 2015; 16: 748-754. doi: 10.1016/j.jamda.2015.04.008; pii: S1525-8610(15)00296-0.
36. Park SW, Goodpaster BH, Strotmeyer ES etal. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 2006; 55: 1813-1818.
37. Sergi G, Veronese N, Fontana L etal. Pre-frailty and risk of cardiovascular disease in elderly men and women: the pro.v.a. study. J Am Coll Cardiol 2015; 65: 976-983.
38. Bouillon K, Kivimäki M, Hamer M etal. Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study. J Am Med Dir Assoc 2013; 14: 851.e1-851.e6.
39. Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, Sinclair AJ. Hypoglycemia in older people - a less well recognized risk factor for frailty. Aging Dis 2015; 6: 156-167.
40. Noale M, Veronese N, Cavallo Perin P etal. Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment. Acta Diabetol 2015 doi: 10.1007/s00592-015-0790-4.
41. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015; 24: 637-646.
42. Landi F, Liperoti R, Russo A etal. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31: 652-658.
43. Maurer MS, Burcham J, Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 2005; 60: 1157-1162.
44. Yau RK, Strotmeyer ES, Resnick HE etal. Diabetes and risk of hospitalized fall injury among older adults. Diabetes Care 2013; 36: 3985-3991.
45. Chiba Y, Kimbara Y, Kodera R etal. Risk factors associated with falls in elderly patients with type 2 diabetes. J Diabetes Complications 2015; 29: 898-902. pii: S1056-8727(15)00219-.
46. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001; 49: 664-672.
47. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078.
48. Schmitz N, Gariépy G, Smith KJ etal. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care 2014; 37: 970-978.
49. Paulson D, Lichtenberg PA. Vascular depression and frailty: a compound threat to longevity among older-old women. Aging Ment Health 2013; 17: 901-910.
50. Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment - a review of the evidence and causal mechanisms. Ageing Res Rev 2013; 12: 840-851.
51. Ní Mhaoláin AM, Fan CW, Romero-Ortuno R etal. Frailty, depression, and anxiety in later life. Int Psychogeriatr 2012; 24: 1265-1274.
52. Willette AA, Johnson SC, Birdsill AC etal. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement 2015; 11: 504-510.
53. Matsuzaki T, Sasaki K, Tanizaki Y etal. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 2010; 75: 764-770.
54. Starks EJ, Patrick O'Grady J, Hoscheidt SM etal. Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOE ε4 carriers. J Alzheimers Dis 2015; 46: 525-533.
55. Hong M, Lee VM. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 1997; 272: 19547-19553.
56. Macuco CR, Batistoni SS, Lopes A etal. Mini-Mental State Examination performance in frail, pre-frail, and non-frail community dwelling older adults in Ermelino Matarazzo, São Paulo, Brazil. Int Psychogeriatr 2012; 24: 1725-1731.
57. Auyeung TW, Lee JS, Kwok T etal. Physical frailty predicts future cognitive decline - a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging 2011; 15: 690-694.
58. Avila-Funes JA, Amieva H, Barberger-Gateau P etal. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc 2009; 57: 453-461.
59. Feinkohl I, Aung PP, Keller M etal. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Diabetes Care 2014; 37: 507-515.
60. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009; 103: 1616-1621.
61. Frisoli A Jr, Ingham SJ, Paes ÂT etal. Frailty predictors and outcomes among older patients with cardiovascular disease: data from Fragicor. Arch Gerontol Geriatr 2015; 61: 1-7.
62. Li Y, Zou Y, Wang S etal. A pilot study of the FRAIL scale on predicting outcomes in Chinese elderly people with type 2 diabetes. J Am Med Dir Assoc 2015; 16: 714.e7-714.e12.
63. Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev 2010; 9: 226-237.
64. Cadore EL, Izquierdo M. Exercise interventions in polypathological aging patients that coexist with diabetes mellitus: improving functional status and quality of life. Age (Dordr) 2015; 37: 9800.
65. Tan S, Li W, Wang J. Effects of six months of combined aerobic and resistance training for elderly patients with a long history of type 2 diabetes. J Sports Sci Med. 2012; 11: 495-501.
66. Bauer J, Biolo G, Cederholm T etal. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013; 14: 542-559.
67. Rahi B, Morais JA, Gaudreau P, Payette H, Shatenstein B. Energy and protein intakes and their association with a decline in functional capacity among diabetic older adults from the NuAge cohort. Eur J Nutr 2015; PMID: 26179475.
68. Lee CG, Boyko EJ, Barrett-Connor E etal. Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care 2011; 34: 2381-2386.
69. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond) 2007; 31: 1302-1310.
70. Skov V, Glintborg D, Knudsen S etal. Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome. PLoS ONE 2008; 3: e2466.
71. Rodríguez-Moctezuma JR, Robles-López G, López-Carmona JM, Gutiérrez-Rosas MJ. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes. Diabetes Obes Metab 2005; 7: 189-192.
72. Wessels B, Ciapaite J, van den Broek NM, Nicolay K, Prompers JJ. Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner. PLoS ONE 2014; 9: e100525.
73. Kane DA, Anderson EJ, Price JW 3rd etal. Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radic Biol Med 2010; 49: 1082-1087.
74. Mele A, Calzolaro S, Cannone G, Cetrone M, Conte D, Tricarico D. Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle. Pharmacol Res Perspect 2014; 2: e00028. doi: 10.1002/prp2.28.
75. Abdulla H, Phillips B, Smith K, Wilkinson D, Atherton PJ, Idris I. Physiological mechanisms of action of incretin and insulin in regulating skeletal muscle metabolism. Curr Diabetes Rev 2014; 10: 231-237.
76. Livingstone SJ, Levin D, Looker HC etal. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 2015; 313: 37-44.
77. Krause MP, Riddell MC, Hawke TJ. Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms. Pediatr Diabetes 2011; 12 (4 Pt 1): 345-364.
78. Han Cho N, Colagiuri S, Distiller L etal. International Diabetes Federation Global Guideline for Managing Older People with Type 2 Diabetes. Brussels: International Diabetes Federation, 2013.